Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model
- PMID: 6149901
Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model
Abstract
Physiologic pharmacokinetic analysis of 4,4'-dichlorobiphenyl, 2,2',3,3',6,6'-hexachlorobiphenyl, and 2,2',4,4',5,5'-hexachlorobiphenyl is presented for the dog and monkey, and the results are compared with previous similar analyses for the rat and mouse. The normalized clearances (ml/min/kg body weight) vary considerably between the dog and the monkey; the rat and the mouse show less species variation. The equilibrium tissue-to-blood distribution ratios for parent and metabolite are generally similar for all four species. The fat compartment has the highest parent distribution ratio for all four species, and the metabolite distribution ratios are much smaller than the parent distribution ratios. Metabolism appears to be a prerequisite to urinary and biliary excretion for all three compounds in each species. Elimination from the body occurs predominantly by the fecal route. The 2,2',4,4',5,5'-hexachlorobiphenyl is more slowly metabolized than the 2,2',3,3',6,6'-isomer in all species, which supports the contention that two adjacent, unsubstituted carbon atoms on the biphenyl ring promote more rapid metabolism.
Similar articles
-
A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat.Drug Metab Dispos. 1977 Jul-Aug;5(4):386-96. Drug Metab Dispos. 1977. PMID: 19218
-
Use of a physiological compartmental model for the rat to describe the pharmacokinetics of several chlorinated biphenyls in the mouse.Drug Metab Dispos. 1980 Nov-Dec;8(6):397-403. Drug Metab Dispos. 1980. PMID: 6109607
-
Pharmacokinetics of 3,3',5,5'-tetrachlorobiphenyl in the male rat.Drug Metab Dispos. 1977 Sep-Oct;5(5):444-50. Drug Metab Dispos. 1977. PMID: 20292
-
Pharmacokinetics of PCBs.Annu Rev Pharmacol Toxicol. 1984;24:85-103. doi: 10.1146/annurev.pa.24.040184.000505. Annu Rev Pharmacol Toxicol. 1984. PMID: 6428301 Review.
-
The construction of a pharmacokinetic model for the disposition of polychlorinated biphenyls in the rat.Clin Pharmacol Ther. 1977 Nov;22(5 Pt 2):765-73. doi: 10.1002/cpt1977225part2765. Clin Pharmacol Ther. 1977. PMID: 410580 Review.
Cited by
-
Animal models for the risk assessment of viral pandemic potential.Lab Anim Res. 2020 Apr 22;36:11. doi: 10.1186/s42826-020-00040-6. eCollection 2020. Lab Anim Res. 2020. PMID: 32337177 Free PMC article. Review.
-
Implications of pharmacokinetic modeling in risk assessment analysis.Environ Health Perspect. 1987 Dec;76:97-106. doi: 10.1289/ehp.877697. Environ Health Perspect. 1987. PMID: 3447907 Free PMC article.
-
Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease.J Proteome Res. 2012 Jul 6;11(7):3805-15. doi: 10.1021/pr300297z. Epub 2012 Jun 21. J Proteome Res. 2012. PMID: 22686559 Free PMC article.
-
Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies.Environ Health Perspect. 2008 Jul;116(7):886-92. doi: 10.1289/ehp.10917. Environ Health Perspect. 2008. PMID: 18629310 Free PMC article.
-
Effects of time-variant exposure on toxic substance response.Environ Health Perspect. 1987 Dec;76:133-9. doi: 10.1289/ehp.8776133. Environ Health Perspect. 1987. PMID: 3329094 Free PMC article.